Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 5, 2009, Pages 830-840

  Ricchi, Matteo ^a   Odoardi, Maria Rosaria ^a   Carulli, Lucia ^a   Anzivino, Claudia ^a   Ballestri, Stefano ^a   Pinetti, Adriano ^a   Fantoni, Luca Isaia ^a   Marra, Fabio ^b   Bertolotti, Marco ^a   Banni, Sebastiano ^c   Lonardo, Amedeo ^a   Carulli, Nicola ^a   Loria, Paola ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF FLORENCE   (Italy)

^c UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Apoptosis; Cell culture techniques; Fatty acids; Fatty liver; Insulin resistance; Saturated and insaturated

Indexed keywords

OLEIC ACID; PALMITIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPID COMPOSITION; LIPID STORAGE; LIVER CELL CULTURE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOPTOSIS; CELL LINE, TUMOR; DOSE-RESPONSE RELATIONSHIP, DRUG; FATTY LIVER; GENE EXPRESSION REGULATION; HEPATOCYTES; HUMANS; INSULIN; OLEIC ACID; PALMITIC ACID; PPAR ALPHA; PPAR GAMMA; RECEPTOR, INSULIN; RNA, MESSENGER; SIGNAL TRANSDUCTION; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRIGLYCERIDES;

EID: 65949090538     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05733.x     Document Type: Article

References (61)

1. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the x-files. Science 2001 294 : 1866 70. (Pubitemid 33101573)
2. Clarke SD. The multi-dimensional regulation of gene expression by fatty acids: polyunsaturated fats as nutrient sensors. Curr. Opin. Lipidol. 2004 15 : 13 18. (Pubitemid 39118012)
3. McGarry JD. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 2002 51 : 7 18. (Pubitemid 34517974)
4. Haslam DW, James WP. Obesity. Lancet 2005 366 : 1197 209. (Pubitemid 41393598)
5. Nehra V, Angulo P, Buchman AL, Lindor KD. Nutritional and metabolic considerations in the etiology of non-alcoholic steatohepatitis. Dig. Dis. Sci. 2001 46 : 2347 52. (Pubitemid 33042332)
6. Musso G, Gambino R, De Michieli F et al. Dietary habits and their relations to insulin resistance and postprandial lipemia in nonalcoholic steatohepatitis. Hepatology 2003 37 : 909 16. (Pubitemid 36397404)
7. Hernandez R, Martinez-Lara E, Canuelo A et al. Steatosis recovery after treatment with a balanced sunflower or olive oil-based diet: involvement of perisinusoidal stellate cells. World J. Gastroenterol. 2005 11 : 7480 5. (Pubitemid 43126030)
8. Cortez-Pinto H, Jesus L, Barros H, Lopes C, Moura MC, Camilo ME. How different is the dietary pattern in non-alcoholic steatohepatitis patients? Clin. Nutr. 2006 25 : 816 23. (Pubitemid 44426431)
9. Wang D, Wei Y, Pagliassotti MJ. Saturated fatty acids promote endoplasmic reticulum stress and liver injury in rats with hepatic steatosis. Endocrinology 2006 147 : 943 51. (Pubitemid 43113013)
10. De Almeida IT, Cortez-Pinto H, Fidalgo G, Rodrigues D, Camilo ME. Plasma total and free fatty acids composition in human non-alcoholic steatohepatitis. Clin. Nutr. 2002 21 : 219 23.
11. Videla LA, Rodrigo R, Araya J, Poniachik J. Oxidative stress and depletion of hepatic long-chain polyunsaturated fatty acids may contribute to nonalcoholic fatty liver disease. Free Radic. Biol. Med. 2004 37 : 1499 507. (Pubitemid 39349251)
12. Samuel VT, Liu ZX, Qu X et al. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 2004 279 : 32345 53. (Pubitemid 39014687)
13. Browning JD, Horton JD. Molecular mediators of hepatic steatosis and liver injury. J. Clin. Invest. 2004 114 : 147 52. (Pubitemid 39071617)
14. Canbay A, Gieseler RK, Gores GJ, Gerken G. The relationship between apoptosis and non-alcoholic fatty liver disease: an evolutionary cornerstone turned pathogenic. Z. Gastroenterol. 2005 43 : 211 17. (Pubitemid 40332918)
15. Unger RH, Orci L. Lipoapoptosis: its mechanism and its diseases. Biochim. Biophys. Acta 2002 1585 : 202 12. (Pubitemid 36092084)
16. Feldstein AE, Canbay A, Angulo P et al. Hepatocyte apoptosis and fas expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 2003 125 : 437 43. (Pubitemid 36929425)
17. Schmitz-Peiffer C, Craig DL, Biden TJ. Ceramide generation is sufficient to account for the inhibition of the insulin-stimulated PKB pathway in C2C12 skeletal muscle cells pretreated with palmitate. J. Biol. Chem. 1999 274 : 24202 10. (Pubitemid 129528468)
18. Baylin A, Kabagambe EK, Siles X, Campos H. Adipose tissue biomarkers of fatty acid intake. Am. J. Clin. Nutr. 2002 76 : 750 7.
19. Feldstein AE, Canbay A, Guicciardi ME, Higuchi H, Bronk SF, Gores GJ. Diet associated hepatic steatosis sensitizes to Fas mediated liver injury in mice. J. Hepatol. 2003 39 : 978 83. (Pubitemid 37523769)
20. Malhi H, Bronk SF, Werneburg NW, Gores GJ. Free fatty acids induce JNK-dependent hepatocyte lipoapoptosis. J. Biol. Chem. 2006 281 : 12093 101. (Pubitemid 43855473)
21. Wei Y, Wang D, Topczewski F, Pagliassotti MJ. Saturated fatty acids induce endoplasmic reticulum stress and apoptosis independently of ceramide in liver cells. Am. J. Physiol. Endocrinol. Metab. 2006 291 : E275 81. (Pubitemid 44035286)
22. Javitt NB. Hep G2 cells as a resource for metabolic studies: lipoprotein, cholesterol, and bile acids. FASEB J. 1990 4 : 161 8. (Pubitemid 20080720)
23. Dashti N, Wolfbauer G. Secretion of lipids, apolipoproteins, and lipoproteins by human hepatoma cell line, HepG2: effects of oleic acid and insulin. J. Lipid Res. 1987 28 : 423 36. (Pubitemid 17055554)
24. Gutierrez-Ruiz MC, Bucio L, Souza V, Gomez JJ, Campos C, Carabez A. Expression of some hepatocyte-like functional properties of WRL-68 cells in culture. In Vitro Cell. Dev. Biol. Anim. 1994 30A : 366 71. (Pubitemid 24172392)
25. Nakabayashi H, Taketa K, Yamane T, Miyazaki M, Miyano K, Sato J. Phenotypical stability of a human hepatoma cell line, HuH-7, in long-term culture with chemically defined medium. Gann 1984 75 : 151 8. (Pubitemid 14155204)
26. Okamoto Y, Tanaka S, Haga Y. Enhanced GLUT2 gene expression in an oleic acid-induced in vitro fatty liver model. Hepatol. Res. 2002 23 : 138 44. (Pubitemid 36113479)
27. Feldstein AE, Werneburg NW, Canbay A et al. Free fatty acids promote hepatic lipotoxicity by stimulating TNF-alpha expression via a lysosomal pathway. Hepatology 2004 40 : 185 94. (Pubitemid 38868937)
28. Gomez-Lechon MJ, Donato MT, Martinez-Romero A, Jimenez N, Castell JV, O'Connor JE. A human hepatocellular in vitro model to investigate steatosis. Chem. Biol. Interact. 2007 165 : 106 16. (Pubitemid 46072796)
29. Ricchi M, Bertolotti M, Anzivino C et al. 17Beta-estradiol prevents cytotoxicity from hydrophobic bile acids in HepG2 and WRL-68 cell cultures. J. Gastroenterol. Hepatol. 2006 21 : 894 901. (Pubitemid 43793290)
30. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 1957 226 : 497 509.
31. Banni S, Carta G, Contini MS et al. Characterization of conjugated diene fatty acids in milk, dairy products, and lamb tissues. J. Nutr. Biochem. 1996 7 : 150 5. (Pubitemid 26128276)
32. Melis MP, Angioni E, Carta G et al. Characterization of conjugated linoleic acid and its metabolites by RP-HPLC with diode array detector. Eur. J. Lipid Sci. Technol. 2001 103 : 617 21. (Pubitemid 33343546)
33. Ip C, Banni S, Angioni E et al. Conjugated linoleic acid-enriched butter fat alters mammary gland morphogenesis and reduces cancer risk in rats. J. Nutr. 1999 129 : 2135 42.
34. Whiteman EL, Cho H, Birnbaum MJ. Role of Akt/protein kinase B in metabolism. Trends Endocrinol. Metab. 2002 13 : 444 51.
35. Cnop M, Hannaert JC, Hoorens A, Eizirik DL, Pipeleers DG. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes 2001 50 : 1771 7. (Pubitemid 33641595)
36. Li Z, Berk M, McIntyre TM, Gores GJ, Feldstein AE. The lysosomal-mitochondrial axis in free fatty acid-induced hepatic lipotoxicity. Hepatology 2008 47 : 1495 503.
37. Listenberger LL, Ory DS, Schaffer JE. Palmitate-induced apoptosis can occur through a ceramide-independent pathway. J. Biol. Chem. 2001 276 : 14890 5. (Pubitemid 37373368)
38. Karaskov E, Scott C, Zhang L, Teodoro T, Ravazzola M, Volchuk A. Chronic palmitate but not oleate exposure induces endoplasmic reticulum stress, which may contribute to INS-1 pancreatic beta-cell apoptosis. Endocrinology 2006 147 : 3398 407. (Pubitemid 43901131)
39. Rakatzi I, Mueller H, Ritzeler O, Tennagels N, Eckel J. Adiponectin counteracts cytokine- and fatty acid-induced apoptosis in the pancreatic beta-cell line INS-1. Diabetologia 2004 47 : 249 58. (Pubitemid 38315361)
40. Ostrander DB, Sparagna GC, Amoscato AA, McMillin JB, Dowhan W. Decreased cardiolipin synthesis corresponds with cytochrome c release in palmitate-induced cardiomyocyte apoptosis. J. Biol. Chem. 2001 276 : 38061 7. (Pubitemid 37384058)
41. Ribeiro PS, Cortez-Pinto H, Sola S et al. Hepatocyte apoptosis, expression of death receptors and activation of NfkappaB in the liver of non-alcoholic and alcoholic steatohepatitis patients. Am. J. Gastroenterol. 2004 99 : 1718 19. (Pubitemid 39237497)
42. Natori S, Rust C, Stadheim LM et al. Hepatocyte apoptosis is a pathologic feature of human alcoholic hepatitis. J. Hepatol. 2001 34 : 248 53. (Pubitemid 32176446)
43. Ghosh S, May MJ, Kopp EB. NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 1998 16 : 225 60. (Pubitemid 28183365)
44. Green DR. Death and NF-kappaB in T cell activation: life at the edge. Mol. Cell 2003 11 : 551 2. (Pubitemid 36385110)
45. Faouzi S, Burckhardt BE, Hanson JC et al. Anti-Fas induces hepatic chemokines and promotes inflammation by an Nfkappa B-independent, caspase-3-dependent pathway. J. Biol. Chem. 2001 276 : 49077 82. (Pubitemid 37370613)
46. Canbay A, Guicciardi ME, Higuchi H et al. Cathepsin B inactivation attenuates hepatic injury and fibrosis during cholestasis. J. Clin. Invest. 2003 112 : 152 9. (Pubitemid 38056351)
47. Canbay A, Taimr P, Torok N et al. Apoptotic body engulfment by a human stellate cell line is profibrogenic. Lab. Invest. 2003 83 : 655 63. (Pubitemid 36618044)
48. Malhi H, Barreyro FJ, Isomoto H, Bronk SF, Gores GJ. Free fatty acids sensitise hepatocytes TRAIL mediated cytotoxicity. Gut 2007 56 : 1124 31. (Pubitemid 47123245)
49. Canbay A, Feldstein AE, Higuchi H et al. Kupffer cell engulfment of apoptotic bodies stimulates death ligand and cytokine expression. Hepatology 2003 38 : 1188 98. (Pubitemid 37314827)
50. Feldstein A, Gores GJ. Steatohepatitis and apoptosis: therapeutic implications. Am. J. Gastroenterol. 2004 99 : 1718 19. (Pubitemid 39237498)
51. Listenberger LL, Han X, Lewis SE et al. Triglyceride accumulation protects against fatty acid-induced lipotoxicity. Proc. Natl. Acad. Sci. USA 2003 100 : 3077 82. (Pubitemid 36356542)
52. Puri P, Baillie RA, Wiest MM et al. A lipidomic analysis of nonalcoholic fatty liver disease. Hepatology 2007 46 : 1081 90. (Pubitemid 350144772)
53. Warensjo E, Ohrvall M, Vessby B. Fatty acid composition and estimated desaturase activities are associated with obesity and lifestyle variables in men and women. Nutr. Metab. Cardiovasc. Dis. 2006 16 : 128 36. (Pubitemid 43384710)
54. Yamaguchi K, Yang L, McCall S et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 2007 45 : 1366 74. (Pubitemid 46918320)
55. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999 116 : 1413 19. (Pubitemid 29258890)
56. Harrison SA, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Clin. Liver Dis. 2004 8 : 861 79. (Pubitemid 39311147)
57. Adams LA, Lymp JF, St Sauver J et al. The natural history of nonalcoholic fatty liver disease: a population-based cohort study. Gastroenterology 2005 129 : 113 21. (Pubitemid 41002048)
58. Lonardo A, Lombardini S, Scaglioni F et al. Hepatic steatosis and insulin resistance: does etiology make a difference? J. Hepatol. 2006 44 : 190 6. (Pubitemid 41772534)
59. Solinas G, Naugler W, Galimi F, Lee MS, Karin M. Saturated fatty acids inhibit induction of insulin gene transcription by JNK-mediated phosphorylation of insulin-receptor substrates. Proc. Natl. Acad. Sci. USA 2006 103 : 16454 9.
60. Donnelly KL, Smith CI, Schwarzenberg SJ, Jessurun J, Boldt MD, Parks EJ. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J. Clin. Invest. 2005 115 : 1343 51. (Pubitemid 40629054)
61. Gentile CL, Pagliassotti MJ. The role of fatty acids in the development and progression of nonalcoholic fatty liver disease. J. Nutr. Biochem. 2008 19 : 567 76.